Display options
Share it on

J Extracell Vesicles. 2018 Mar 26;7(1):1454777. doi: 10.1080/20013078.2018.1454777. eCollection 2018.

Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation.

Journal of extracellular vesicles

Thøger Nielsen, Anne Flou Kristensen, Shona Pedersen, Gunna Christiansen, Søren Risom Kristensen

Affiliations

  1. Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
  2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  3. Department of Biomedicine, Aarhus University, Aarhus, Denmark.

PMID: 29696077 PMCID: PMC5912197 DOI: 10.1080/20013078.2018.1454777

Abstract

Tissue factor (TF) is the main initiator of coagulation and procoagulant phospholipids (PPL) are key components in promoting coagulation activity in blood. Both TF and PPL may be presented on the surface of extracellular vesicles (EVs), thus contributing to their procoagulant activity. These EVs may constitute a substantial part of pathological hypercoagulability that is responsible for triggering a higher risk of thrombosis in certain patients. The aim of this study was to describe a model system for the isolation of EVs required for investigating their effect on coagulation. Differential ultracentrifugation (DUC) with and without a single washing step was used to isolate and evaluate the procoagulant capacity of EVs from healthy volunteers through analysis of thrombin generation and PPL activity. Ultracentrifugation at 20,000 × 

Keywords: Electron microscopy; extracellular vesicles; isolation; microvesicles; procoagulant phospholipids; thrombin generation; tissue factor

References

  1. J Thromb Haemost. 2013 Apr 2;:null - PubMed
  2. J Extracell Vesicles. 2013 May 27;2:null - PubMed
  3. Blood. 2005 Apr 1;105(7):2764-70 - PubMed
  4. J Cell Biol. 2013 Feb 18;200(4):373-83 - PubMed
  5. Circ Res. 2011 May 13;108(10):1284-97 - PubMed
  6. Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 - PubMed
  7. J Extracell Vesicles. 2016 Oct 31;5:32945 - PubMed
  8. PLoS One. 2015 Dec 21;10(12):e0145686 - PubMed
  9. Methods. 2012 Feb;56(2):293-304 - PubMed
  10. Mol Cell Proteomics. 2010 Jun;9(6):1324-38 - PubMed
  11. Thromb Res. 2016 Mar;139:90-7 - PubMed
  12. J Extracell Vesicles. 2016 Sep 27;5:31242 - PubMed
  13. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):249-53 - PubMed
  14. J Extracell Vesicles. 2017 Apr 4;6(1):1308779 - PubMed
  15. Thromb Haemost. 2000 Mar;83(3):445-54 - PubMed
  16. J Thromb Haemost. 2010 Dec;8(12):2596-607 - PubMed
  17. Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1687-93 - PubMed
  18. J Thromb Haemost. 2008 Sep;6(9):1517-24 - PubMed
  19. Int Immunol. 2005 Jul;17(7):879-87 - PubMed
  20. J Thromb Haemost. 2007 Mar;5(3):520-7 - PubMed
  21. Clin Cancer Res. 2009 Nov 15;15(22):6830-40 - PubMed
  22. J Thromb Haemost. 2014 Apr;12(4):515-8 - PubMed
  23. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2311-5 - PubMed
  24. Proteomics. 2013 Nov;13(22):3354-64 - PubMed
  25. J Thromb Haemost. 2014 Oct;12(10):1678-86 - PubMed
  26. J Extracell Vesicles. 2013 Mar 18;2:null - PubMed
  27. J Extracell Vesicles. 2015 Nov 11;4:29260 - PubMed
  28. Cell Mol Life Sci. 2011 Aug;68(16):2667-88 - PubMed
  29. Am J Hematol. 2014 Jan;89(1):68-73 - PubMed
  30. J Thromb Haemost. 2008 Jun;6(6):913-9 - PubMed

Publication Types